Morgan Stanley Starts STERIS (STE) at Equalweight, 'Clean bill of health'

May 30, 2023 5:21 AM EDT
Get Alerts STE Hot Sheet
Price: $221.05 -2.12%

Rating Summary:
    7 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 10 | New: 37
Join SI Premium – FREE
(Updated - May 30, 2023 6:03 AM EDT)

Morgan Stanley analyst Patrick Wood initiates coverage on STERIS (NYSE: STE) with a Equalweight rating and a price target of $206.00.

The analyst comments "We think STE is in great shape from a volume and price perspective, and while we see some upside risk later this year on margins, we think much of this is captured in valuation. Initiate at Equal-weight with a PT of $206."

For an analyst ratings summary and ratings history on STERIS click here. For more ratings news on STERIS click here.

Shares of STERIS closed at $200.44 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Morgan Stanley